Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class I · High risk Terminated Initiated Apr 12, 2015 (12 years ago)

Testosterone Cypionate 200 mg/mL in Sesame oil

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Incorrect Product Formulation: Vials labeled as Testosterone Cypionate 200 mg/mL in Sesame Oil are being recalled because they contains Estradiol Valerate 20 mg/mL.

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

Testosterone Cypionate 200 mg/mL in Sesame oil, 10 mL amber glass vial, Rx Only, Lot# T-1201S14, Compounded by Strohecker's Pharmacy.

Drug: Testosterone

Recalling firm
Stroheckers Inc Pharmacy
Origin
OR, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1088-2015 · FDA notice

Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Testosterone recalls

See all
Class II · Moderate risk

Testosterone 200mg

Presence of Foreign substance - potential presence of metal particulate matter

Ongoing Particulate / foreign matter F.H. INVESTMENTS, Inc. (dba Asteria Health) D-0329-2026
Class II · Moderate risk

Testosterone 100mg

Presence of Foreign substance - potential presence of metal particulate matter

Ongoing Particulate / foreign matter F.H. INVESTMENTS, Inc. (dba Asteria Health) D-0328-2026
Class II · Moderate risk

Testosterone 75mg

Presence of Foreign substance - potential presence of metal particulate matter

Ongoing Particulate / foreign matter F.H. INVESTMENTS, Inc. (dba Asteria Health) D-0327-2026

Other cgmp deviation recalls from 2015

All cgmp deviation recalls
Class II · Moderate risk

Oxygen

cGMP Deviations; trailer may not have met GMP requirements prior to filling

Terminated cGMP deviation AGA Gas Inc NDC 33237-001-01 D-0779-2016
Class II · Moderate risk

Repaskin 30

cGMP Deviations; product does not comply with cGMP requirements

Ongoing cGMP deviation Sesderma, SL NDC 63181-0010-1 D-0849-2016